The many reasons a person may sleepwalk include genetics, sleep deprivation, stress, migraines, fever, breathing disorders, ...

Alkermes plc ALKS has made steady progress with its portfolio of proprietary products — Vivitrol (alcohol and opioid ...

Huntington’s disease is an inherited neurodegenerative disorder that causes problems with movement, behavior, and cognitive ...

在现代医学的长河中，非典型抗精神病药物（Atypical antipsychotics, ...

Lybalvi (olanzapine and samidorphan), too, has been witnessing strong sales uptake. The company expects to generate sales between $320 million and $340 million in 2025 from Lybalvi. Shares of ...

Campaigns against drug abuse have mainly focused on low-income neighbourhoods and slums—leaving the menace to flourish in ...

This issue of Nature Metabolism presents findings demonstrating that glucagon-like peptide-2 (GLP-2) minimizes metabolic disruptions caused by the antipsychotic olanzapine.

A 33-year-old woman hears brutal and frightening voices daily but continues her college studies. A middle-aged man, who served in the Navy and has since struggled with substance ...

An investigation into a deadly shooting involving police and a chainsaw-wielding man at an Illinois nursing home has found no ...

and olanzapine as well as clozapine and risperidone in treating the disorder, and recommends a range of psychiatric and rehabilitation approaches. More than 91 researchers and clinicians and more ...

Investing.com — Sunshine Biopharma Inc. (NASDAQ: SBFM )，一家制药公司，今日宣布已达成战略协议，将在加拿大市场推广两种新型通用抗生素。该公司计划通过其子公司Nora Pharma在获得监管批准后的六到九个月内推出这些产品。根据 InvestingPro ...